Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Evil big pharma: myth or material?

April 6, 2011 Research and Development, Sales and Marketing Les Rose, industry reputation

In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …
Feature

Merck acquires eyecare specialist Inspire

April 6, 2011 Research and Development, Sales and Marketing Inspire, Merck, eye care

Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …
News
Boehringer Andreas Barner

Boehringer bets on Pradaxa to fill portfolio gaps

April 6, 2011 Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa

Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …
News
pfizer_belgium_kris_westelinck

Kris Westelinck appointed president of Pfizer Belgium

April 5, 2011 Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, researcha and development, sales and marketing

Pfizer Belgium has promoted Kris Westelinck to the role of president. Kris was previously managing director and head of Pfizer’s …
Appointment

ABPI appoints new head

April 5, 2011 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, appointment

The ABPI has appointed former Prudential communications director Stephen Whitehead as its new head. He joins the UK pharma industry …
News
Lansley

Government urged to slow pace of NHS reforms

April 4, 2011 Sales and Marketing GP consortia, Liberating the NHS, NHS reform

The Government should slow down its health reform programme to allow GPs to grow into their new role, the think …
News

New BMS drug trumps peg-interferon alpha

April 4, 2011 Research and Development, Sales and Marketing BMS, EASL, hepatitis C, pegintron alfa

Bristol-Myers Squibb has been given a boost by trial results which suggest its compound for hepatitis C, PEG-Interferon lambda, is …
News

TcL Pharma appoints French pharma veterans

April 1, 2011 Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment

TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …
News

AstraZeneca pays $1.1bn to resolve tax affairs

March 31, 2011 Sales and Marketing AstraZeneca, tax

AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …
News
Cephalon

Valeant makes $5.7 billion hostile bid for Cephalon

March 31, 2011 Research and Development, Sales and Marketing Cephalon, Valeant

Valeant has made a hostile bid for Cephalon, but analysts believe its offer is too low for the deal to …
News
Erbitux (cetixumab)

Merck re-submits Erbitux to the EMA for lung cancer

March 30, 2011 Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer

Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …
News
Doctor patient

New pharma skills needed for GP commissioning changes

March 30, 2011 Business Services, Sales and Marketing NHS reforms, skills, training

With GP-led commissioning taking the NHS into new territory, market access is facing a major shake up. In January, one …
Feature

EU Clinical Trials Register is Launched

March 29, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has announced the launch of its EU Clinical Trials Register. This online register allows public …
News
Press release
Roche

Roche changes raise Novartis takeover question

March 29, 2011 Sales and Marketing Novartis, Roche, mergers and acquisitions

Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom. The Roche family …
News

New melanoma drug approved by FDA

March 28, 2011 Sales and Marketing BMS, melanoma

Yervoy, Bristol Myers Squibb’s new treatment for advanced skin cancer has gained approval in the US. The drug is the …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026